Beta-Glucan and Monoclonal Antibody 3F8 in Treating Patients With Metastatic Neuroblastoma
Clinical trial NCT00492167 · COMPLETED
Trial details
- NCT number
- NCT00492167
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2005-09-09
- Primary completion
- 2022-03-04
- Enrollment
- 45
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.